Almanack Investment Partners, Llc. Abb Vie Inc. Transaction History

Almanack Investment Partners, Llc.

$602 Million
Q4 2024

A detailed history of Almanack Investment Partners, Llc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Almanack Investment Partners, Llc. holds 1,419 shares of ABBV stock, worth $270,461. This represents 0.04% of its overall portfolio holdings.

Number of Shares

1,419

Previous 1,419 -0.0%

Holding current value

$270,461

Previous $280,000 10.0%

% of portfolio

0.04%

Previous 0.05%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	BUY	$163.84 - $199.33 $232,488 - $282,849	1,419 New	1,419 $280,000
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $655,884 - $752,255	-4,887 Reduced 73.41%	1,770 $238,000
Q2 2022 Aug 12, 2022	BUY	$137.62 - $174.96 $457,999 - $582,266	3,328 Added 99.97%	6,657 $1.02 Million
Q1 2022 May 13, 2022	BUY	$131.98 - $163.75 $18,873 - $23,416	143 Added 4.49%	3,329 $540,000
Q4 2021 Feb 11, 2022	SELL	$107.43 - $135.93 $19,229 - $24,331	-179 Reduced 5.32%	3,186 $431,000
Q3 2021 Nov 04, 2021	BUY	$106.4 - $120.78 $33,516 - $38,045	315 Added 10.33%	3,365 $363,000
Q2 2021 Aug 04, 2021	SELL	$105.21 - $117.21 $51,132 - $56,964	-486 Reduced 13.74%	3,050 $344,000
Q1 2021 May 11, 2021	BUY	$102.3 - $112.62 $84,397 - $92,911	825 Added 30.43%	3,536 $383,000
Q4 2020 Feb 03, 2021	SELL	$80.49 - $108.67 $603,192 - $814,372	-7,494 Reduced 73.43%	2,711 $291,000
Q3 2020 Nov 12, 2020	BUY	$85.91 - $100.83 $69,673 - $81,773	811 Added 8.63%	10,205 $1.02 Million
Q2 2020 Aug 10, 2020	BUY	$73.37 - $98.18 $689,237 - $922,302	9,394 New	9,394 $922,000
Q3 2019 Nov 08, 2019	SELL	$62.98 - $75.72 $122,496 - $147,275	-1,945 Closed	0 $0
Q2 2019 Jul 31, 2019	BUY	$65.7 - $83.98 $127,786 - $163,341	1,945 New	1,945 $0
Q1 2019 May 15, 2019	SELL	$77.14 - $90.79 $89,173 - $104,953	-1,156 Closed	0 $0
Q4 2018 Jan 25, 2019	SELL	$77.85 - $96.01 $5,605 - $6,912	-72 Reduced 5.86%	1,156 $107,000
Q3 2018 Nov 13, 2018	SELL	$88.91 - $98.84 $128,208 - $142,527	-1,442 Reduced 54.01%	1,228 $108,000
Q2 2018 Aug 15, 2018	SELL	$89.78 - $106.23 $10,055 - $11,897	-112 Reduced 4.03%	2,670 $247,000
Q1 2018 May 15, 2018	BUY	$92.01 - $123.21 $92 - $123	1 Added 0.04%	2,782 $263,000
Q4 2017 Feb 13, 2018	BUY	$89.56 - $98.21 $28,838 - $31,623	322 Added 13.09%	2,781 $269,000
Q3 2017 Nov 13, 2017	BUY	$69.85 - $89.22 $171,761 - $219,391	2,459	2,459 $219,000

Others Institutions Holding ABBV

# of Institutions

3,943

Shares Held

1.26B

Call Options Held

16.8M

Put Options Held

12.1M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $337B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Almanack Investment Partners, Llc., based on Form 13F filings with the SEC.

News

Stay updated on Almanack Investment Partners, Llc. with notifications on news.

Account

Almanack Investment Partners, Llc. Abb Vie Inc. Transaction History